Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have been given an average recommendation of "Buy" by the eight research firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and four have issued a strong buy rating on the company.
A number of analysts have weighed in on the company. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Royal Bank Of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th.
Check Out Our Latest Research Report on RBGLY
Reckitt Benckiser Group Trading Up 0.4%
RBGLY stock opened at $13.85 on Wednesday. The company has a current ratio of 0.58, a quick ratio of 0.39 and a debt-to-equity ratio of 1.08. The business's fifty day simple moving average is $13.33 and its two-hundred day simple moving average is $13.01. Reckitt Benckiser Group has a twelve month low of $10.43 and a twelve month high of $14.15.
Reckitt Benckiser Group Company Profile
(
Get Free ReportReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
